Partnering with Diagnostics
Passionate about science - regardless of where it comes from
Roche was one of the first companies to recognise the importance of external innovation. Diagnostics has been partnering for more than 20 years with companies and research institutes worldwide. Since then, we have maintained a model that values external innovation as highly as our own internal development and established collaborations as the cornerstone of our R&D strategy.
Who we are
Roche Diagnostics is the market leader in the in vitro diagnostics business and provides the largest number of test results, empowering physicians and patients to make informed health decisions.
Roche is market leader in in-vitro diagnostics
tests conducted with Roche instruments in 2021
acquisitions since 2014
active in-licensing agreements
active out-licensing agreements
R&D investment in 2024 across the Roche Diagnostics Division
Diagnostics partnering areas of interest
Where we are
Diagnostics Partnering offers speed, flexibility and accessibility to our partners. We have offices in Santa Clara, Tucson, Pleasanton, Boston, Basel (HQ), Rotkreuz, Penzberg and Shanghai.
:quality(90)/)
Our partnering process
The Roche partnering process can be encapsulated in four steps.
Defining our search
Identifying partners
Personalising deals
Building relationships
At each step we can modify and tailor the relationship to the specific needs of each potential partner and depending on what is best for the asset. We find that this flexible approach is welcomed by our partners, and in our experience delivers the best results.